ABT
Price
$112.69
Change
-$0.60 (-0.53%)
Updated
Dec 18, 04:48 PM (EDT)
35 days until earnings call
ATRC
Price
$31.22
Change
-$0.28 (-0.89%)
Updated
Dec 18, 10:45 AM (EDT)
69 days until earnings call
Ad is loading...

ABT vs ATRC

Header iconABT vs ATRC Comparison
Open Charts ABT vs ATRCBanner chart's image
Abbott Laboratories
Price$112.69
Change-$0.60 (-0.53%)
Volume$2.56K
CapitalizationN/A
AtriCure
Price$31.22
Change-$0.28 (-0.89%)
Volume$812
CapitalizationN/A
ABT vs ATRC Comparison Chart
Loading...
ABT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABT vs. ATRC commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a Hold and ATRC is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (ABT: $113.29 vs. ATRC: $31.50)
Brand notoriety: ABT: Notable vs. ATRC: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ABT: 113% vs. ATRC: 83%
Market capitalization -- ABT: $194.5B vs. ATRC: $1.45B
ABT [@Medical Specialties] is valued at $194.5B. ATRC’s [@Medical Specialties] market capitalization is $1.45B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABT’s FA Score shows that 1 FA rating(s) are green whileATRC’s FA Score has 0 green FA rating(s).

  • ABT’s FA Score: 1 green, 4 red.
  • ATRC’s FA Score: 0 green, 5 red.
According to our system of comparison, ABT is a better buy in the long-term than ATRC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABT’s TA Score shows that 2 TA indicator(s) are bullish while ATRC’s TA Score has 3 bullish TA indicator(s).

  • ABT’s TA Score: 2 bullish, 6 bearish.
  • ATRC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ATRC is a better buy in the short-term than ABT.

Price Growth

ABT (@Medical Specialties) experienced а -1.91% price change this week, while ATRC (@Medical Specialties) price change was -7.30% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.08%. For the same industry, the average monthly price growth was +3.94%, and the average quarterly price growth was +5.39%.

Reported Earning Dates

ABT is expected to report earnings on Jan 22, 2025.

ATRC is expected to report earnings on Feb 25, 2025.

Industries' Descriptions

@Medical Specialties (-2.08% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABT($194B) has a higher market cap than ATRC($1.45B). ATRC has higher P/E ratio than ABT: ATRC (36.76) vs ABT (34.38). ABT YTD gains are higher at: 4.979 vs. ATRC (-11.740). ABT has higher annual earnings (EBITDA): 10.5B vs. ATRC (-8.11M). ABT has more cash in the bank: 7.28B vs. ATRC (137M). ATRC has less debt than ABT: ATRC (74.5M) vs ABT (15.6B). ABT has higher revenues than ATRC: ABT (40.1B) vs ATRC (399M).
ABTATRCABT / ATRC
Capitalization194B1.45B13,398%
EBITDA10.5B-8.11M-129,486%
Gain YTD4.979-11.740-42%
P/E Ratio34.3836.7694%
Revenue40.1B399M10,050%
Total Cash7.28B137M5,313%
Total Debt15.6B74.5M20,940%
FUNDAMENTALS RATINGS
ABT vs ATRC: Fundamental Ratings
ABT
ATRC
OUTLOOK RATING
1..100
6257
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
67
Overvalued
PROFIT vs RISK RATING
1..100
4193
SMR RATING
1..100
5893
PRICE GROWTH RATING
1..100
5549
P/E GROWTH RATING
1..100
5797
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABT's Valuation (10) in the Medical Specialties industry is somewhat better than the same rating for ATRC (67). This means that ABT’s stock grew somewhat faster than ATRC’s over the last 12 months.

ABT's Profit vs Risk Rating (41) in the Medical Specialties industry is somewhat better than the same rating for ATRC (93). This means that ABT’s stock grew somewhat faster than ATRC’s over the last 12 months.

ABT's SMR Rating (58) in the Medical Specialties industry is somewhat better than the same rating for ATRC (93). This means that ABT’s stock grew somewhat faster than ATRC’s over the last 12 months.

ATRC's Price Growth Rating (49) in the Medical Specialties industry is in the same range as ABT (55). This means that ATRC’s stock grew similarly to ABT’s over the last 12 months.

ABT's P/E Growth Rating (57) in the Medical Specialties industry is somewhat better than the same rating for ATRC (97). This means that ABT’s stock grew somewhat faster than ATRC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABTATRC
RSI
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
44%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
52%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
ABT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ABT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABT has been loosely correlated with MDT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then MDT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABT
1D Price
Change %
ABT100%
+0.59%
MDT - ABT
46%
Loosely correlated
+0.02%
SYK - ABT
42%
Loosely correlated
-0.51%
ATRC - ABT
41%
Loosely correlated
-0.13%
BSX - ABT
40%
Loosely correlated
-0.03%
TFX - ABT
39%
Loosely correlated
+0.58%
More

ATRC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with TFX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then TFX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
-0.13%
TFX - ATRC
44%
Loosely correlated
+0.58%
ABT - ATRC
41%
Loosely correlated
+0.59%
MDT - ATRC
41%
Loosely correlated
+0.02%
STE - ATRC
40%
Loosely correlated
-0.72%
BNGO - ATRC
39%
Loosely correlated
-6.01%
More